129 related articles for article (PubMed ID: 25559540)
1. Letter to the editor: μ-crystallin/CRYM functions as a ketimine-reducing enzyme and plays a role in thyroid hormone bioavailability due to strong inhibition/regulation by thyroid hormones.
Hallen A; Cooper AJ
J Clin Endocrinol Metab; 2015 Jan; 100(1):L15-6. PubMed ID: 25559540
[No Abstract] [Full Text] [Related]
2. Response to letter to the editor.
Fernández-Real JM
J Clin Endocrinol Metab; 2015 Jan; 100(1):L17. PubMed ID: 25559541
[No Abstract] [Full Text] [Related]
3. Adipose tissue μ-crystallin is a thyroid hormone-binding protein associated with systemic insulin sensitivity.
Serrano M; Moreno M; Ortega FJ; Xifra G; Ricart W; Moreno-Navarrete JM; Fernández-Real JM
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2259-68. PubMed ID: 25057873
[TBL] [Abstract][Full Text] [Related]
4. Insights into Enzyme Catalysis and Thyroid Hormone Regulation of Cerebral Ketimine Reductase/μ-Crystallin Under Physiological Conditions.
Hallen A; Cooper AJ; Jamie JF; Karuso P
Neurochem Res; 2015 Jun; 40(6):1252-66. PubMed ID: 25931162
[TBL] [Abstract][Full Text] [Related]
5. µ-Crystallin: A thyroid hormone binding protein.
Kinney CJ; Bloch RJ
Endocr Regul; 2021 May; 55(2):89-102. PubMed ID: 34020530
[TBL] [Abstract][Full Text] [Related]
6. Mammalian forebrain ketimine reductase identified as μ-crystallin; potential regulation by thyroid hormones.
Hallen A; Cooper AJ; Jamie JF; Haynes PA; Willows RD
J Neurochem; 2011 Aug; 118(3):379-87. PubMed ID: 21332720
[TBL] [Abstract][Full Text] [Related]
7. CRYM mutations cause deafness through thyroid hormone binding properties in the fibrocytes of the cochlea.
Oshima A; Suzuki S; Takumi Y; Hashizume K; Abe S; Usami S
J Med Genet; 2006 Jun; 43(6):e25. PubMed ID: 16740909
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of mouse mu-crystallin complexed with NADPH and the T3 thyroid hormone.
Borel F; Hachi I; Palencia A; Gaillard MC; Ferrer JL
FEBS J; 2014 Mar; 281(6):1598-612. PubMed ID: 24467707
[TBL] [Abstract][Full Text] [Related]
9. Emerging role of T3-binding protein μ-crystallin (CRYM) in health and disease.
Aksoy O; Hantusch B; Kenner L
Trends Endocrinol Metab; 2022 Dec; 33(12):804-816. PubMed ID: 36344381
[TBL] [Abstract][Full Text] [Related]
10. μ-Crystallin controls muscle function through thyroid hormone action.
Seko D; Ogawa S; Li TS; Taimura A; Ono Y
FASEB J; 2016 May; 30(5):1733-40. PubMed ID: 26718889
[TBL] [Abstract][Full Text] [Related]
11. Crystallin-gazing: unveiling enzymatic activity.
Reed PW; Bloch RJ
J Neurochem; 2011 Aug; 118(3):315-6. PubMed ID: 21418222
[No Abstract] [Full Text] [Related]
12. Identification of mu-crystallin as an androgen-regulated gene in human prostate cancer.
Malinowska K; Cavarretta IT; Susani M; Wrulich OA; Uberall F; Kenner L; Culig Z
Prostate; 2009 Jul; 69(10):1109-18. PubMed ID: 19353593
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal Control of Thyroid Binding and the Pipecolate Pathway in the Brain.
Hallen A; Cooper AJ
Neurochem Res; 2017 Jan; 42(1):217-243. PubMed ID: 27518089
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms in endocrinology: the crosstalk between thyroid gland and adipose tissue: signal integration in health and disease.
Santini F; Marzullo P; Rotondi M; Ceccarini G; Pagano L; Ippolito S; Chiovato L; Biondi B
Eur J Endocrinol; 2014 Oct; 171(4):R137-52. PubMed ID: 25214234
[TBL] [Abstract][Full Text] [Related]
15. Thyroid Function in Human Obesity: Underlying Mechanisms.
Fontenelle LC; Feitosa MM; Severo JS; Freitas TE; Morais JB; Torres-Leal FL; Henriques GS; do Nascimento Marreiro D
Horm Metab Res; 2016 Dec; 48(12):787-794. PubMed ID: 27923249
[TBL] [Abstract][Full Text] [Related]
16. Spiking expression of mu-crystallin mRNA during treatment with methimazole in patients with graves' hyperthyroidism.
Suzuki S; Takei M; Nishio S; Inaba H; Sato A; Yamazaki M; Shinomiya K; Hashizume K
Horm Metab Res; 2009 Jul; 41(7):548-53. PubMed ID: 19280551
[TBL] [Abstract][Full Text] [Related]
17. Roux-en-Y gastric bypass and calorie restriction induce comparable time-dependent effects on thyroid hormone function tests in obese female subjects.
Lips MA; Pijl H; van Klinken JB; de Groot GH; Janssen IM; Van Ramshorst B; Van Wagensveld BA; Swank DJ; Van Dielen F; Smit JW
Eur J Endocrinol; 2013 Sep; 169(3):339-47. PubMed ID: 23811187
[TBL] [Abstract][Full Text] [Related]
18. mu-crystallin, a NADPH-dependent T(3)-binding protein in cytosol.
Suzuki S; Mori J; Hashizume K
Trends Endocrinol Metab; 2007 Sep; 18(7):286-9. PubMed ID: 17692531
[TBL] [Abstract][Full Text] [Related]
19. Expression of CRYM in different rat organs during development and its decreased expression in degenerating pyramidal tracts in amyotrophic lateral sclerosis.
Hommyo R; Suzuki SO; Abolhassani N; Hamasaki H; Shijo M; Maeda N; Honda H; Nakabeppu Y; Iwaki T
Neuropathology; 2018 Jun; 38(3):247-259. PubMed ID: 29603402
[TBL] [Abstract][Full Text] [Related]
20. Beyond low plasma T3: local thyroid hormone metabolism during inflammation and infection.
Boelen A; Kwakkel J; Fliers E
Endocr Rev; 2011 Oct; 32(5):670-93. PubMed ID: 21791567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]